Jona Mata, MD (@jonamata26) 's Twitter Profile
Jona Mata, MD

@jonamata26

Oncology Fellow @hopkins_hemonc | MedEd | Onc Nerd @tumortalks | Proud @tamumedicine, @utaustin & @oslerresidency grad 🤘🏼

ID: 1301687670586978309

calendar_today04-09-2020 01:05:06

116 Tweet

431 Followers

567 Following

tumortalks (@tumortalks) 's Twitter Profile Photo

During breast cancer awareness month, we want to talk about the most common cause of cancer death in women worldwide. Listen to this great episode on breast cancer with Dr. Jessie Tao to learn more! 🎀 🔗podcasters.spotify.com/pod/show/tumor… Jona Mata, MD Johns Hopkins Hematology and Oncology Fellowship Beatriz Wills

During breast cancer awareness month, we want to talk about the most common cause of cancer death in women worldwide. Listen to this great episode on breast cancer with Dr. Jessie Tao to learn more! 🎀
🔗podcasters.spotify.com/pod/show/tumor…
<a href="/jonamata26/">Jona Mata, MD</a> <a href="/Hopkins_HemOnc/">Johns Hopkins Hematology and Oncology Fellowship</a> <a href="/BeatrizWills/">Beatriz Wills</a>
tumortalks (@tumortalks) 's Twitter Profile Photo

Did you know Hodgkin Lymphoma can lead to itching and pain with alcohol use? Interesting stuff! This week, we go back to talking about liquid malignancies with our very own, @willsbeatriz. Learn more interesting bits about Hodgkin beyond Reed-Sternberg in this week's episode!

Did you know Hodgkin Lymphoma can lead to itching and pain with alcohol use? Interesting stuff! This week, we go back to talking about liquid malignancies with our very own, @willsbeatriz. Learn more interesting bits about Hodgkin beyond Reed-Sternberg in this week's episode!
tumortalks (@tumortalks) 's Twitter Profile Photo

Ahead of World MDS Day, we wanted to talk about an important myeloid neoplasm, Myelodysplastic Syndrome (MDS). We are fortunate to have our expert and former The Osler Medical Residency ACS, Dr. Amy Dezern break down the basics of MDS. Learn more in this week's episode of Tumor Talks!

Ahead of World MDS Day, we wanted to talk about an important myeloid neoplasm, Myelodysplastic Syndrome (MDS). We are fortunate to have our expert and former <a href="/oslerresidency/">The Osler Medical Residency</a> ACS, Dr. Amy Dezern break down the basics of MDS. Learn more in this week's episode of Tumor Talks!
tumortalks (@tumortalks) 's Twitter Profile Photo

Don't liver us hanging, listen to this amazing HCC episode with Johns Hopkins Hematology and Oncology Fellowship expert, Dr. Mark Yarchoan in this week's Tumor Talks episode! 🔗spotifyanchor-web.app.link/e/QxoyvoH8eEb #MedEd #HCC #OncMedEd

Don't liver us hanging, listen to this amazing HCC episode with <a href="/Hopkins_HemOnc/">Johns Hopkins Hematology and Oncology Fellowship</a> expert, Dr. Mark Yarchoan in this week's Tumor Talks episode! 🔗spotifyanchor-web.app.link/e/QxoyvoH8eEb
#MedEd #HCC #OncMedEd
tumortalks (@tumortalks) 's Twitter Profile Photo

Urine for a great episode talking about Non-Muscle Invasive Bladder Cancer with amazing Urologic Oncologist, Dr. Hong Truong of Penn State! Listen to this week's episode for plenty of pearls. spotifyanchor-web.app.link/e/kTtkLO1mCEb

Urine for a great episode talking about Non-Muscle Invasive Bladder Cancer with amazing Urologic Oncologist, Dr. <a href="/HongTruongMD/">Hong Truong</a> of Penn State! Listen to this week's episode for plenty of pearls.
spotifyanchor-web.app.link/e/kTtkLO1mCEb
Jona Mata, MD (@jonamata26) 's Twitter Profile Photo

I’m so excited to continue the dream of training at Hopkins now as a future Oncologist!! 🩸👩🏻‍⚕️An honor to match Johns Hopkins Hematology and Oncology Fellowship and excited to continue to learn from the best. A big thank you to my family & teachers who got me here today, this one is for you! The Osler Medical Residency

Jona Mata, MD (@jonamata26) 's Twitter Profile Photo

Extremely humbled, honored and excited to serve as a future The Osler Medical Residency ACS with this all-star team and a real life Wonder Woman at the helm of it all. To be able to teach what my teachers taught me is truly a dream come true! Bryan Broderick, MD, MEHP Armani Hawes

Extremely humbled, honored and excited to serve as a future <a href="/OslerResidency/">The Osler Medical Residency</a> ACS with this all-star team and a real life Wonder Woman at the helm of it all. To be able to teach what my teachers taught me is truly a dream come true! <a href="/BBroderickMD/">Bryan Broderick, MD, MEHP</a> <a href="/Armani_Hawes/">Armani Hawes</a>
NEJM (@nejm) 's Twitter Profile Photo

The addition of subcutaneous daratumumab to bortezomib, lenalidomide, and dexamethasone therapy and to lenalidomide maintenance therapy had a significant benefit on progression-free survival among patients with multiple myeloma. Full PERSEUS trial results: nej.md/3Nm3j33

The addition of subcutaneous daratumumab to bortezomib, lenalidomide, and dexamethasone therapy and to lenalidomide maintenance therapy had a significant benefit on progression-free survival among patients with multiple myeloma. Full PERSEUS trial results: nej.md/3Nm3j33
Seth Martin (@sethshaymartin) 's Twitter Profile Photo

Exceptional teaching by Jona Mata, MD and John Connolly today at The Osler Medical Residency Barker Firm Grand Rounds. “The Hepatic Head-Scratcher: A Curious Case of Acute Liver Failure” Fascinating case that turned out to have hemophagocytic lymphohistiocytosis secondary to anaplasmosis.

Exceptional teaching by <a href="/jonamata26/">Jona Mata, MD</a> and John Connolly today at <a href="/OslerResidency/">The Osler Medical Residency</a> Barker Firm Grand Rounds.

“The Hepatic Head-Scratcher: A Curious Case of Acute Liver Failure”

Fascinating case that turned out to have  hemophagocytic lymphohistiocytosis secondary to anaplasmosis.
Cameron Blazoski, M.D. (@cameronblazoski) 's Twitter Profile Photo

Proud to author this piece in JACC Journals Women’s CV disease remains under-recognized and under-treated, but the 2023 CCD guidelines offer important guidelines for treating female patients with ASCVD. Extra thanks to Garima Sharma M.D and Roger Blumenthal bit.ly/23ccd

Proud to author this piece in <a href="/JACCJournals/">JACC Journals</a>

Women’s CV disease remains under-recognized and under-treated, but the 2023 CCD guidelines offer important guidelines for treating female patients with ASCVD.

Extra thanks to <a href="/GarimaVSharmaMD/">Garima Sharma M.D</a> and <a href="/rblument1/">Roger Blumenthal</a>

bit.ly/23ccd
Jona Mata, MD (@jonamata26) 's Twitter Profile Photo

Proud to share our findings on Primary and Secondary Graft Failure in patients receiving AlloHSCT + PTCy as GVHD prophylaxis A very special thanks to my grand-ACS Dr. Alex Ambinder for his awesome mentorship astctjournal.org/article/S2666-…

Paul O'Rourke (@orourkejr) 's Twitter Profile Photo

Super honored to be among this group of amazing Johns Hopkins Medicine educators: Tina Zhang Susrutha Kotwal r @dc1116 Peter Abadir. Thanks IEE for the recognition and for making Hopkins such a wonderful community for #MedEd educators!

Super honored to be among this group of amazing <a href="/HopkinsMedicine/">Johns Hopkins Medicine</a> educators: <a href="/tinazhangmd/">Tina Zhang</a> <a href="/KotwalSusrutha/">Susrutha Kotwal</a> <a href="/dromron/">r</a> @dc1116 <a href="/Rock1MD/">Peter Abadir</a>.  

Thanks <a href="/Hopkins_IEE/">IEE</a> for the recognition and for making Hopkins such a wonderful community for #MedEd educators!
NEJM (@nejm) 's Twitter Profile Photo

Presented at #ESMO24: Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m

Presented at #ESMO24: 

Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m